COMMUNIQUÉS West-GlobeNewswire

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2017
06/09/2017
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Enzymatica recruits Chief Financial Officer
06/09/2017
Press release Lund, 6 September, 2017 Enzymatica recruits Chief Financial Officer Enzymatica has recruited Therese Filmersson as its new Chief Financial Officer - CFO. Therese joins us from Procurator, one of Sweden's [...]
ObsEva SA Announces the Completion of Patient Recruitment in the IMPLANT2 Phase 3 Clinical Trial in Assisted Reproductive Technology Ahead of Schedule
06/09/2017
Geneva, Switzerland and Boston, MA - 06 September, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017
06/09/2017
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Interim Results for the six months ended 30 June 2017 INTEREST Phase III Traumakine ® trial patient recruitment to complete in Q4 2017 and FDA advice received [...]
Helsinn Group: Announces Upcoming Presentation of Phase III data of NEPA (fosnetupitant/ palonosetron) IV at ESMO 2017
06/09/2017
Helsinn Group Announces Upcoming Presentation of Phase III data of NEPA (fosnetupitant/ palonosetron) IV at ESMO 2017 Preliminary findings demonstrate intravenous NEPA to be safe and well-tolerated, with a similar [...]
BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins
06/09/2017
MAINZ, Germany, Sept. 06, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it has entered into a broad and comprehensive [...]
MDxHealth Prepares for Growth with Executive Team Expansion
06/09/2017
Michael K. Brawer, MD Appointed as Chief Medical Officer PRESS RELEASE / REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, September 6, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced the [...]
MDxHealth consolide son équipe de direction pour accompagner la croissance
06/09/2017
Michael K. Brawer, MD est nommé Chief Medical Officer COMMUNIQUÉ DE PRESSE / INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 CEST, 6 septembre, 2017 - MDxHealth SA (Euronext : MDXH.BR) a annoncé la [...]
Novavax to Participate in the Citi 12th Annual Biotech Conference
05/09/2017
GAITHERSBURG, Md., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in Citi's 12th Annual Biotech Conference. Conference details are as follows: Date: Thursday [...]
Medtronic EVP & CVG President Mike Coyle to Speak at Wells Fargo Healthcare Conference
05/09/2017
DUBLIN - September 5, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 2017 Wells Fargo Healthcare Conference on Thursday, September 7, 2017, in [...]
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital
05/09/2017
Oslo (Norway), 5 September 2017 - Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the "Company"). 1. Options exercised and [...]
Diaxonhit : acquisition définitive la société GENBIO aux Etats-Unis
05/09/2017
DIAXONHIT acquiert la société GENBIO aux Etats-Unis Réalisation de l'acquisition stratégique d'une entreprise commerciale pour accélérer le développement du groupe aux Etats-Unis et à l'international GENBIO, une société [...]
VALNEVA : Déclaration d'actions et de droits de vote - août 2017
05/09/2017
VALNEVA Déclaration d'actions et de droits de vote - AOUT 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
05/09/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
05/09/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Medtronic Launches Long Term Clinical Study Program of INFUSE Bone Graft in Two Common Spine Procedures: PLF and TLIF
05/09/2017
First Patient Enrolled in Initial Posterolateral Fusion Study DUBLIN - September 5, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of a long term clinical study program to collect prospective data on INFUSE [...]
Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia® in the US
05/09/2017
Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia ® in the US Zykadia ® (ceritinib) is an approved treatment for patients with metastatic non-small cell lung cancer (NSCLC) [...]
Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) as Adjunctive Therapy in Patients With Major Depressive Disorder
05/09/2017
WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Auris Medical to Host Scientific Symposium at the AAO-HNSF Annual Meeting
05/09/2017
ZUG, Switzerland, Sept. 5, 2017 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, [...]

Pages